(Q36926453)

17 August 2017

1 reference

title

Role of complete lymphadenectomy in endometrioid uterine cancer (English)

1 reference

17 August 2017

1 reference

John K Chan

1

1 reference

17 August 2017

Daniel S Kapp

series ordinal

2

1 reference

17 August 2017

publication date

1 September 2007

1 reference

Lancet Oncology Commission

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

9

1 reference

17 August 2017

page(s)

831-841

1 reference

17 August 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

An analysis of approaches to the treatment of endometrial cancer in Western Europe: A CTF study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgical management of endometrial cancer in Slovak Republic.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

A questionnaire survey on current surgical procedures for endometrial cancer in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Nodal distribution and its significance in FIGO stage IIIc endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Pelvic lymphadenectomy in the surgical treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Radiologic staging in patients with endometrial cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Carcinoma of the corpus uteri.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

The National Cancer Data Base report on endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Lymph node sampling and survival in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

1 reference

7 January 2021

ACOG Practice Bulletin #65: Management of Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgical staging for endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgical staging endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Staging and therapeutic value of lymphadenectomy in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Endometrial cancer: is surgical staging necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Stage I corpus cancer: is teletherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Analysis of FIGO Stage IIIc endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgery without radiotherapy for primary treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Endometrial Carcinomas With Lymph Node Involvement: Novel Histopathologic Factors for Predicting Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgical staging for patients presenting with grade 1 endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Endometrial carcinoma: paraaortic dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Surgical staging of endometrial cancer: does the patient benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

The effect of chemotherapy on lymph node metastases in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970275-9

7 January 2021

10.1016/S1470-2045(07)70275-9

Identifiers

DOI

1 reference

17 August 2017

1 reference